Unilink Pharma Private Limited, a active private limited company, was established on 23 February 2005 in Chennai-600017., Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TN2005PTC055459. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹1.60 Cr.
Formerly known as Unilink Drugs And Pharmaceuticals Private Limited. It upholds a compliant status. Its leadership includes Sreenivasan Karunakaran (Whole-Time Director), Karunakaran Vijaya (Managing Director). Past directors included Sekar Donna Padman, Tpalanisamy, Ramkumar Palanisamy. It holds ₹23.53 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at New No.111, Old No.23Parthasarathypuram T Nagar, Chennai-600017., Tamil Nadu, 600017.
U24232TN2005PTC055459
055459
23 February 2005
₹3.00 Cr
₹1.60 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Unilink Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sreenivasan Karunakaran | Whole-Time Director | 02 Oct 2009 | Current |
| Karunakaran Vijaya | Managing Director | 23 Feb 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 03 Jun 2009 | Past |
| Pramod Abcsdd | Director | 06 Dec 2021 | Past |
| Pramod Abcsdd | Whole-Time Director | 03 Jun 2009 | Past |
| Pramod Abcsdd | Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Director | 01 Apr 2019 | Past |
| Pramod Abcsdd | Managing Director | 31 Mar 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Unilink Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.87% increase. The company also saw a slight decrease in profitability, with a 4.66% decrease in profit. The company's net worth Soared by an impressive increase of 12.29%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Unilink Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹235,300,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2020 | State Bank Of India | ₹1.97 Cr | Open |
| 08 Jan 2020 | Others | ₹3.00 Cr | Open |
| 19 Mar 2014 | Icici Bank Limited | ₹1.40 Cr | Open |
| 01 Oct 2009 | Icici Home Finance Company Limited | ₹1.24 Cr | Open |
| 28 Mar 2005 | State Bank Of India | ₹15.92 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Unilink Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Unilink Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unilink Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Unilink Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Unilink Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was completed.
Progress on A charge with State Bank Of India of Rs. 15.92 Cr registered on 28 Mar 2005 with Charge ID 80020355 was modified on 26 Mar 2024. was documented.
Progress on A charge with State Bank Of India amounted to Rs. 1.97 Cr with Charge ID 100367338 was registered on 30 May 2020. was documented.
Progress on A charge with Others amounted to Rs. 3.00 Cr with Charge ID 100313511 was registered on 08 Jan 2020. was documented.
A charge with Icici Bank Limited amounted to Rs. 1.40 Cr with Charge ID 10485266 was registered on 19 Mar 2014. was recorded as a recent event.
The CIN of Unilink Pharma Private Limited is U24232TN2005PTC055459.
Unilink Pharma Private Limited is headquartered at New No.111, Old No.23Parthasarathypuram T Nagar, Chennai-600017., Tamil Nadu, 600017.
Unilink Pharma Private Limited was incorporated on 23 February 2005.
The current directors of Unilink Pharma Private Limited are
The primary industry of Unilink Pharma Private Limited is Manufacturing.
Unilink Pharma Private Limited is unlisted.
The authorized capital of Unilink Pharma Private Limited is ₹3.00 Cr, and the paid-up capital is ₹1.60 Cr.
The compliance status of Unilink Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX